tiprankstipranks
Trending News
More News >
StemCell Institute (JP:7096)
:7096
Japanese Market

StemCell Institute (7096) Price & Analysis

Compare
0 Followers

7096 Stock Chart & Stats


Financials

Options Prices

Currently, No data available
---

Ownership Overview

0.05%99.95%
Insiders
0.05%
Mutual Funds
― Other Institutional Investors
99.95% Public Companies and
Individual Investors

7096 FAQ

What was StemCell Institute’s price range in the past 12 months?
StemCell Institute lowest stock price was ¥998.00 and its highest was ¥1923.00 in the past 12 months.
    What is StemCell Institute’s market cap?
    StemCell Institute’s market cap is ¥10.82B.
      When is StemCell Institute’s upcoming earnings report date?
      StemCell Institute’s upcoming earnings report date is Aug 06, 2025 which is in 50 days.
        How were StemCell Institute’s earnings last quarter?
        StemCell Institute released its earnings results on May 13, 2025. The company reported ¥4.49 earnings per share for the quarter, beating the consensus estimate of N/A by ¥4.49.
          Is StemCell Institute overvalued?
          According to Wall Street analysts StemCell Institute’s price is currently Overvalued. Get more investment ideas with TipRanks Premium
            Does StemCell Institute pay dividends?
            StemCell Institute pays a Notavailable dividend of ¥25 which represents an annual dividend yield of N/A. See more information on StemCell Institute dividends here
              What is StemCell Institute’s EPS estimate?
              StemCell Institute’s EPS estimate for its next earnings report is not yet available.
              How many shares outstanding does StemCell Institute have?
              StemCell Institute has 10,246,600 shares outstanding.
                What happened to StemCell Institute’s price movement after its last earnings report?
                StemCell Institute reported an EPS of ¥4.49 in its last earnings report, beating expectations of N/A. Following the earnings report the stock price went down -1.093%.
                  Which hedge fund is a major shareholder of StemCell Institute?
                  Currently, no hedge funds are holding shares in JP:7096

                  Company Description

                  StemCell Institute

                  StemCell Institute Inc. engages in the stem cell banking business in Japan. The company is also involved in research and development of medical treatments using stem cells, as well as engages in banking of blood vessel cells businesses. StemCell Institute Inc. was incorporated in 1999 and is headquartered in Tokyo, Japan. StemCell Institute Inc. is a subsidiary of Trim Medical Holdings Inc.
                  Similar Stocks
                  Company
                  Price & Change
                  Follow
                  StemRIM Inc.
                  CellSource Co., Ltd.
                  ReproCELL Inc.
                  Japan Tissue Engineering Co., Ltd.
                  CellSeed Inc.
                  Popular Stocks
                  What am I Missing?
                  Make informed decisions based on Top Analysts' activity
                  Know what industry insiders are buying
                  Get actionable alerts from top Wall Street Analysts
                  Find out before anyone else which stock is going to shoot up
                  Get powerful stock screeners & detailed portfolio analysis